MX2017009193A - Lente de contacto iontoforetica. - Google Patents

Lente de contacto iontoforetica.

Info

Publication number
MX2017009193A
MX2017009193A MX2017009193A MX2017009193A MX2017009193A MX 2017009193 A MX2017009193 A MX 2017009193A MX 2017009193 A MX2017009193 A MX 2017009193A MX 2017009193 A MX2017009193 A MX 2017009193A MX 2017009193 A MX2017009193 A MX 2017009193A
Authority
MX
Mexico
Prior art keywords
charged
therapeutic composition
charged therapeutic
current source
compound
Prior art date
Application number
MX2017009193A
Other languages
English (en)
Inventor
Manzo Michael
Original Assignee
Eyegate Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eyegate Pharmaceuticals Inc filed Critical Eyegate Pharmaceuticals Inc
Publication of MX2017009193A publication Critical patent/MX2017009193A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Neurology (AREA)

Abstract

Se proveen lentes de contacto para terapia iontoforética ocular, cuyas implementaciones incluyen un depósito adaptado para contener un compuesto terapéutico cargado, una fuente de corriente que provee corriente iontoforética a la composición terapéutica cargada que afecta el suministro de la composición terapéutica cargada en un globo ocular, y un circuito de detección que controla la fuente de corriente para mantener una escala de pH seleccionada de la composición terapéutica cargada; modalidades alternativas incluyen electrodos de sacrificio activos para generar iones suficientes para proveer una fuerza repulsiva electromotriz al compuesto cargado para efectuar el transporte en el tejido ocular.
MX2017009193A 2015-01-22 2016-01-22 Lente de contacto iontoforetica. MX2017009193A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562106578P 2015-01-22 2015-01-22
PCT/US2016/014636 WO2016118933A1 (en) 2015-01-22 2016-01-22 Iontophoretic contact lens

Publications (1)

Publication Number Publication Date
MX2017009193A true MX2017009193A (es) 2017-12-12

Family

ID=56417852

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017009193A MX2017009193A (es) 2015-01-22 2016-01-22 Lente de contacto iontoforetica.

Country Status (9)

Country Link
US (1) US9937074B2 (es)
EP (1) EP3247452A4 (es)
JP (1) JP2018502639A (es)
CN (1) CN106999711A (es)
AU (1) AU2016209028A1 (es)
BR (1) BR112017009054A2 (es)
CA (1) CA2973595A1 (es)
MX (1) MX2017009193A (es)
WO (1) WO2016118933A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190093214A (ko) 2016-12-13 2019-08-08 베타 테라퓨틱스 피티와이 리미티드 헤파라나제 억제제 및 그의 용도
US11787783B2 (en) 2016-12-13 2023-10-17 Beta Therapeutics Pty Ltd Heparanase inhibitors and use thereof
DE102017213056A1 (de) * 2017-07-28 2019-01-31 Continental Teves Ag & Co. Ohg Verfahren zum Unterdrücken von Bremsgeräuschen, zentraler Server, Fahrzeugsteuerungsmodul und Speichermedium
WO2020028829A1 (en) * 2018-08-02 2020-02-06 University Of Florida Research Foundation Methods and compositions for iontophoretic drug delivery to the eye
US20210393957A1 (en) * 2018-10-02 2021-12-23 Tufts Medical Center, Inc. Systems and Methods for Sensing and Correcting Electrical Activity of Nerve Tissue
KR102137437B1 (ko) 2018-11-06 2020-07-24 한국과학기술연구원 비침습적 약물 전달용 스마트 콘택트렌즈
US11464674B2 (en) 2019-01-09 2022-10-11 Twenty Twenty Therapeutics Llc Programmable therapeutic agent delivery from eye mounted device
CN113784691A (zh) * 2019-01-09 2021-12-10 二十二十治疗学有限责任公司 眼戴式治疗剂释放装置
US20220117724A1 (en) * 2019-03-04 2022-04-21 Tohoku University Method of absorbing or discharging water of ophthalmic medical device and ophthalmic medical device
US20220183880A1 (en) * 2019-04-02 2022-06-16 The Regents Of The University Of California Method and apparatus to modify the cornea using electrochemistry
CN110367927B (zh) * 2019-08-01 2022-04-08 中山大学 青光眼眼压连续检测系统及其检测方法
WO2022026720A1 (en) * 2020-07-31 2022-02-03 Board Of Regents Of The University Of Nebraska Hydrogel ionic circuit based devices for electrical stimulation and drug therapy
CN114355628A (zh) * 2020-09-29 2022-04-15 鼎硕光学股份有限公司 光学装置及其制造方法
CN113413541A (zh) * 2021-06-17 2021-09-21 中央民族大学 一种利用环状电极的眼部离子电渗透药物输送设备及方法
US20230135281A1 (en) * 2021-10-28 2023-05-04 Twenty Twenty Therapeutics Llc Controlled release of a therapeutic from an ophthalmic device with a locally enhanced concentration of chloride ions

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4915685A (en) * 1986-03-19 1990-04-10 Petelenz Tomasz J Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange
US6544193B2 (en) 1996-09-04 2003-04-08 Marcio Marc Abreu Noninvasive measurement of chemical substances
FR2773320B1 (fr) 1998-01-05 2000-03-03 Optisinvest Dispositif pour le transfert intraoculaire de produits actifs par iontophorese
US7346389B1 (en) 1998-09-24 2008-03-18 Newsome David A Dilation enhancer with pre-medicated contact lenses
AU4239300A (en) * 1999-04-16 2000-11-02 Johnson & Johnson Consumer Companies, Inc. Electrotransport delivery system comprising internal sensors
US6539251B2 (en) 1999-05-25 2003-03-25 Iomed, Inc. Ocular iontophoretic apparatus
US6319240B1 (en) 1999-05-25 2001-11-20 Iomed, Inc. Methods and apparatus for ocular iontophoresis
US6579276B2 (en) 2001-01-22 2003-06-17 Iomed, Inc. Ocular iontophoretic device and method for inhibiting vascular endothelial growth factor (VEGF) using the same
US6697668B2 (en) 2001-01-25 2004-02-24 Iomed, Inc. Ocular iontophoretic device and method for using the same
US20020107508A1 (en) 2001-02-05 2002-08-08 Burnett Daniel R. Incisionless corneal sculpting technique and devices
FR2830766B1 (fr) 2001-10-12 2004-03-12 Optis France Sa Dispositif de delivrance de medicaments par iontophorese transpalpebrale
FR2830767B1 (fr) 2001-10-12 2004-03-12 Optis France Sa Dispositif de delivrance de medicaments par iontophorese ou electroporation introculaire
PL205827B1 (pl) 2001-10-31 2010-05-31 Tti Ellebeau Urządzenie do jontoforezy
IL147921A0 (en) 2002-01-31 2002-08-14 Abdulrazik Mohammad A method for treating central nervous system disorders by ocular dosing
US6801804B2 (en) 2002-05-03 2004-10-05 Aciont, Inc. Device and method for monitoring and controlling electrical resistance at a tissue site undergoing iontophoresis
FR2869531B1 (fr) 2004-04-30 2006-07-14 Optis France Sa Sa Dispositif de iontophorese oculaire diminuant les irritations
BRPI0509334A (pt) 2004-04-30 2007-10-16 Eyegate Pharma S A dispositivo de iontoforese ocular, que diminui as irritações
US8246949B2 (en) * 2004-10-27 2012-08-21 Aciont, Inc. Methods and devices for sustained in-vivo release of an active agent
WO2006072887A1 (en) 2005-01-05 2006-07-13 Eyegate Pharma Sa Ocular iontophoresis device for delivering sirna and aptamers
EP1968540A2 (en) 2005-08-05 2008-09-17 Universite De Geneve Topical drug delivery by iontophoresis
US8755880B2 (en) 2005-10-24 2014-06-17 Aciont, Inc. Intraocular iontophoretic device and associated methods
US20070260171A1 (en) * 2005-09-27 2007-11-08 Higuchi John W Intraocular iontophoretic device and associated methods
JP2009509656A (ja) 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 生体界面に活性物質を送達するイオントフォレーシス装置における動作不良を検出するための方法及びシステム
JP2009509659A (ja) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 生体界面への活性物質の送達のイオントフォレーシス装置及び方法
US8634907B2 (en) * 2005-10-24 2014-01-21 Aciont, Inc. Intraocular iontophoretic device and associated methods
US8099162B2 (en) 2005-11-29 2012-01-17 Eyegate Pharma, S.A.S. Ocular iontophoresis device
US20070299386A1 (en) 2006-06-23 2007-12-27 Minu, L.L.C. Delivery of an ocular agent using iontophoresis
WO2008013913A2 (en) 2006-07-26 2008-01-31 Aciont, Inc. Method and device for minimally invasive site specific ocular drug delivery
WO2008125908A2 (en) 2006-12-05 2008-10-23 Eyegate Pharma S.A. Enhanced retinal delivery of a nucleic acid through iontophoresis
KR101604238B1 (ko) 2007-09-28 2016-03-17 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 전기 발생 미립자 및 이의 용도
US8480638B2 (en) * 2007-10-04 2013-07-09 Aciont, Inc. Intraocular iontophoretic device and associated methods
CA2716390C (en) 2008-02-25 2016-08-23 Eyegate Pharma S.A.S. Enhanced delivery of a therapeutic to ocular tissues through iontophoresis
US20100040669A1 (en) 2008-08-12 2010-02-18 Higuchi John W Non-Invasive Ocular Delivery of Rapamycin
CN102341146B (zh) 2008-12-31 2015-09-23 艾盖茨药品公司 具有缓冲的眼用离子电渗用体系和方法
MX347934B (es) 2011-01-12 2017-05-18 Sooft Italia Spa Dispositivo y método para el suministro de riboflavina en la córnea, mediante iontoforesis, para el tratamiento de queratocono.
WO2012162459A1 (en) 2011-05-26 2012-11-29 Pepose Jay Device and method for administering eye medications
US8857983B2 (en) 2012-01-26 2014-10-14 Johnson & Johnson Vision Care, Inc. Ophthalmic lens assembly having an integrated antenna structure
US20140107025A1 (en) 2012-04-16 2014-04-17 Jade Therapeutics, Llc Ocular drug delivery system
MY188854A (en) * 2012-06-29 2022-01-10 Johnson & Johnson Vision Care Method and ophthalmic device for galvanic healing of an eye
US20140190839A1 (en) 2012-08-06 2014-07-10 Google Inc. Contact lenses having two-electrode electrochemical sensors
US8971978B2 (en) 2012-08-21 2015-03-03 Google Inc. Contact lens with integrated pulse oximeter
US8960899B2 (en) 2012-09-26 2015-02-24 Google Inc. Assembling thin silicon chips on a contact lens
WO2014074477A2 (en) * 2012-11-07 2014-05-15 Emmetrope Ophthalmics Llc Magnetic contact lenses and methods of treatment and diagnosis using the same
CN203389001U (zh) 2013-05-30 2014-01-15 中山大学中山眼科中心 一种眼后段透巩膜控释给药装置
US9101309B1 (en) 2013-11-26 2015-08-11 Google Inc. Method and system for measuring retinal
US9289123B2 (en) 2013-12-16 2016-03-22 Verily Life Sciences Llc Contact lens for measuring intraocular pressure
US9761874B2 (en) 2013-12-30 2017-09-12 Verily Life Sciences Llc Fabrication methods for batteries
US9678361B2 (en) 2014-06-13 2017-06-13 Verily Life Sciences Llc Power delivery for accommodation by an eye-mountable device

Also Published As

Publication number Publication date
EP3247452A1 (en) 2017-11-29
AU2016209028A1 (en) 2017-05-11
US9937074B2 (en) 2018-04-10
CN106999711A (zh) 2017-08-01
JP2018502639A (ja) 2018-02-01
EP3247452A4 (en) 2018-11-14
WO2016118933A1 (en) 2016-07-28
BR112017009054A2 (pt) 2018-01-30
CA2973595A1 (en) 2016-07-28
US20160213514A1 (en) 2016-07-28

Similar Documents

Publication Publication Date Title
MX2017009193A (es) Lente de contacto iontoforetica.
MX2017005204A (es) Dispositivos y métodos de estimulación para tratar el ojo seco.
EP3558446A4 (en) "INTELLIGENT" ELECTRODES SET FOR TRANSCUTANEOUS ELECTRIC NERVOUS STIMULATION (TENS)
EP3740279A4 (en) TREATMENT TIP WITH PROTECTED ELECTRODES
EP3930035A4 (en) ELECTRODE POLE PIECE, ELECTROCHEMICAL DEVICE
EP4403138A3 (en) Device and method with reduced pacemaker rate in heart valve replacement
EA201590502A1 (ru) Система доставки глазного имплантата
EP3872908A4 (en) Electrode pole piece and electrochemical device
EP4302736A3 (en) Ophthalmic implant for delivering therapeutic substances
EP3468659A4 (en) DEVICE FOR PROVIDING ELECTRIC ELECTRICITY TO THE BODY AND RELATED METHODS FOR THERAPY
MX2017011165A (es) Sistemas y métodos de compresión de plantilla de pie.
NZ737871A (en) Electroporation system for controlled localized therapeutics delivery
MY197519A (en) Notch pathway signaling inhibitor compounds
EP2593179A4 (en) DEPOSITION REMOVAL INSIDE AND OUTSIDE CIRCULATORY SYSTEMS
PT3074083T (pt) Dispositivo para a implantação transcutânea de elétrodos de marca-passo epicárdicos
MX2016016090A (es) Composicion oftalmica para el tratamiento de infeccion ocular.
WO2016100972A3 (en) Intraocular delivery of bioactive molecules using iontophoresis
EA201490845A1 (ru) Улучшенная сшивающая композиция, доставляемая способом ионтофореза, пригодная для лечения кератоконуса
WO2008108026A1 (ja) 刺激電流付与装置および刺激電流付与装置の制御方法
WO2019057511A3 (en) Electrical method of delivering hyaluronic acid through the skin
MX2010006019A (es) Metodos para administrar acido ribonucleico pequeño de interferencia (arnsi) mediante iontoforesis.
EP3481395A4 (en) EYE ADMINISTRATION OF CELL PERMEATION THERAPEUTIC AGENTS FOR THE TREATMENT OF RETINAEDEMA
PH12019501785A1 (en) Intranasal composition comprising betahistine
EP3936184A4 (en) ELECTRODE FOR ELECTROSTIMULATION THERAPY AND THERAPEUTIC ELECTROSTIMULATION DEVICE
NZ590356A (en) Administration of the drug sumatriptan by iontophoresis